INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $105 | -99.4% | 3 | -99.2% | 0.00% | -100.0% |
| Q2 2022 | $19,000 | -85.2% | 366 | -79.3% | 0.01% | -84.8% |
| Q1 2022 | $128,000 | -39.6% | 1,767 | -1.3% | 0.03% | -36.5% |
| Q4 2021 | $212,000 | +236.5% | 1,791 | +281.9% | 0.05% | +100.0% |
| Q3 2021 | $63,000 | -75.2% | 469 | -70.1% | 0.03% | -64.4% |
| Q2 2021 | $254,000 | +137.4% | 1,570 | +18.1% | 0.07% | +102.8% |
| Q1 2021 | $107,000 | +3466.7% | 1,329 | +2727.7% | 0.04% | +1700.0% |
| Q4 2020 | $3,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |